In conclusion, we found that ERCC1 rs11615 and XPFrs2276465 may substantially contribute to the future design of individualized cancer treatment in gastric cancer patients.
Genotyping of ERCC1 (rs2298881, rs3212986, and rs11615) and XPF (rs2276465, rs6498486, and rs2276466) was performed in a 384-well plate format on the MassARRAY(®) platform.